GM Jatropha X8#34 was placed for transgene flow assessment in the open field trial on Semakau Island, Singapore, between 2015 and 2017 to evaluate the potential gene flow to its non-GM counterparts and related species. The trial featured the GM Jatropha event X8#34, which is characterized by high oleic acid content, marker-free, and a homozygous transgene. The study focused on cross-pollination from the GM event to non-GM plants, analyzing factors such as distance, wind and insects mediated transfer, using event-specific multiplex PCR analysis of F1 seeds. Pollen dispersal by wind was also assessed to understand the extent of distance traveled and pollen load. Our results showed the maximum observed transgene flow was 4.5%, occurring in non-GM plants located 2 meters in third quarter of 2016, average for four quarters is 2.57%. However, as the distance increased, the transgene flow decreased significantly, at 4 meters distance observed 0.8% in fourth quarter and an average 0.25%. Transgene flow was not observed beyond 4 meters. These results are consistent with the exponential decrease in Jatropha pollen dispersed and captured by traps over distance, with no pollen detected beyond 6 meters through wind dispersal. Furthermore, no intrageneric transgene flow was detected from GM Jatropha to , nor intergeneric transgene flow to related weedy species such as , , or (Castor bean), under open-field conditions (2015-2017). The findings suggest that Jatropha pollination is primarily facilitated by short-distance foraging insects, or overlapping branches between adjacent trees enhances cross-pollination rate due to denser floral display, and attracts more pollinators. An adequate separation distance (>8 meters) is sufficient to prevent unintended transgene flow from GM Jatropha to non-GM Jatropha in Singapore ecological conditions. Additionally, transgene flow between GM Jatropha and related horticultural shrub () or intergeneric relatives like , , and castor bean is unlikely under open field conditions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/21645698.2025.2470484 | DOI Listing |
J Immunol
March 2025
Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, United States.
B cell depletion is an efficacious therapy for multiple sclerosis, but its long-term safety profile in the gastrointestinal tract has not been specifically studied. This is of importance because the gut is the largest reservoir of IgA in the body, which maintains gut homeostasis in part by regulating the composition of the gut microbiota. This was addressed by development of a prolonged B cell depletion model using human CD20 transgenic mice and B cell depletion with the anti-human CD20 antibodies rituximab, a humanized mouse monoclonal, and 2H7, the mouse precursor to ocrelizumab.
View Article and Find Full Text PDFSovrem Tekhnologii Med
March 2025
MD, PhD, Head of the Laboratory of Solid Tumor Immunotherapy; Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency of Russia, 1, Bldg. 10, Ostrovityanova St., Moscow, 117513, Russia; Senior Researcher, Laboratory of Cell Technologies; Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies of the Federal Medical Biological Agency of Russia, 28 Orekhovy Blvd., Moscow, 115682, Russia; Senior Researcher, Laboratory of Molecular Regeneration Mechanisms; Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences, 32 Vavilov St., Moscow, 119991, Russia.
Unlabelled: Glioblastoma is the most aggressive primary brain tumor with poor prognosis characterized by resistance to standard treatments and immune evasion. Regulatory T lymphocytes (Tregs) play a key role in immune suppression in the tumor microenvironment and can be used as targets for malignant gliomas therapy. is to study migration of Tregs to the tumor site in the process of dynamic glioblastoma growth on the transgenic C57Bl/6-FoxP3-eGFP mouse line.
View Article and Find Full Text PDFMol Neurodegener
March 2025
VIB Center for Brain and Disease Research and Department of Neurosciences, KU Leuven, Louvain, Belgium.
Background: Recent studies highlight the critical role of microglia in neurodegenerative disorders, and emphasize the need for humanized models to accurately study microglial responses. Human-mouse microglia xenotransplantation models are a valuable platform for functional studies and for testing therapeutic approaches, yet currently those models are only available for academic research. This hampers their implementation for the development and testing of medication that targets human microglia.
View Article and Find Full Text PDFMethods Mol Biol
March 2025
Achucarro Basque Center for Neuroscience, Leioa, Spain.
Neural stem cells (NSCs) are essential for the generation of new neurons and also exert regulatory functions within their niche. NSCs are altered in many pathological conditions, and their role as a therapeutic target is being increasingly studied. Isolating a pure population of NSCs from the brain is challenging due to the lack of unique biomarkers.
View Article and Find Full Text PDFJ Neurochem
March 2025
Koç University Research Center for Translational Medicine (KUTTAM), Koç University, İstanbul, Türkiye.
Central nervous system (CNS) pericytes play crucial roles in vascular development and blood-brain barrier maturation during prenatal development, as well as in regulating cerebral blood flow in adults. They have also been implicated in the pathogenesis of numerous neurological disorders. However, the behavior of pericytes in the adult brain after injury remains poorly understood, partly due to limitations in existing pericyte ablation models.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!